Printable page for all IPOs that have date "scheduled".
This week's IPOs have bold border. Close Window


Company: Cancer Prevention Pharmaceuticals
Symbol: CPP
Price: $12.00-$14.00
Description: They are a clinical-stage biopharmaceutical company formed primarily to develop and commercialize therapeutic agents for the treatment and prevention of certain pre-cancerous conditions, orphan diseases (i.e., rare diseases) and gastrointestinal conditions.
Trade Date: 0/0
Shares: 1.25 million
Type: IPO
Underwriter(s)   Co Manager(s)

Aegis Capital  


Company: China Online Education Group
Symbol: COE
Price: $18.00-$20.00
Description: They are a leading online education platform in China, with core expertise in English education.
Trade Date: 0/0
Shares: 2.4 million ADSs
Type: IPO
Underwriter(s)   Co Manager(s)

Morgan Stanley, Credit Suisse  


Company: Clearside Biomedical
Symbol: CLSD
Price: $14.00-$16.00
Description: They are a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye.
Trade Date: 0/0
Shares: 4 million
Type: IPO
Underwriter(s)   Co Manager(s)

Cowen and Company, Stifel   Needham & Co., Wedbush PacGrow


Company: Moleculin Biotech, Inc.
Symbol: MBRX
Price: $5.00-$6.00
Description: They are a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, many of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, which they refer to as MD Anderson.
Trade Date: 6/2
Shares: 2 million
Type: IPO
Underwriter(s)   Co Manager(s)

Bonwick Capital Partners LLC, Network 1 Financial Securities  


Company: Nant Health
Symbol: NH
Price: 12.50-$15.50
Description: They are a leading next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses.
Trade Date: 6/2
Shares: 6.5 million
Type: IPO
Underwriter(s)   Co Manager(s)

Jefferies, Cowen and Company   First Analysis Securities Corp., Canaccord Genuity, FBR


Company: Sensus Healthcare
Symbol: SRTSU
Price: $6.25-$6.25
Description: They are a medical device company, headquartered in Boca Raton, Florida, specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy.
Trade Date: 6/3
Shares: 1.8 million
Type: IPO
Underwriter(s)   Co Manager(s)

Northland Capital Markets, Neidiger Tucker Bruner Inc